<http://schema.org/description>
"A clinical trial of a vaccine, led by Stanford University School of Medicine researchers and designed to combat type-1 diabetes, has delivered initially promising results, suggesting that it may selectively counter the errant immune response that causes the disease."^^<http://www.w3.org/2001/XMLSchema#string>
<http://medicalxpress.com/news/2013-06-dna-reverse-vaccine-immune-cells.html>